Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems ...

Wegovy Zepbound cost-effectiveness report finds both drugs remain valuable at higher prices despite affordability concerns, per ICER analysis.

Plus, the Trump administration is expected to release finalized Medicare payment rules for doctors and hospitals as soon as ...

Pfizer is suing over some unsolicited competition in its nearly $5 billion bid to buy the drugmaker Metsera. New York-based ...

Founded in 2022 by Population Health Partners and ARCH Venture Partners, the biotech venture giant led by Bob Nelsen, Metsera ...

Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...

Amy Schumer seems to be feeling herself after losing weight. The comedian — who has admitted to using weight loss drugs to ...

Amy Schumer feels "so grateful" to be pain free. The Life and Beth actress - who has six-year-old son Gene with husband Chris ...

Jesse had always been chubby growing up in his hometown of Santa Paula, California, just outside Los Angeles, where he was ...

A major international study led by researchers at University College London has found that semaglutide, the active ingredient ...

Judging from the numbers I'm seeing, the black market for weight-loss jabs isn't small-scale. This is a massive operation.

Lilly’s quarterly results Thursday, combined with Novo Nordisk’s unsolicited offer for a startup, confirm the $72 billion ...